Page last updated: 2024-08-23

raloxifene hydrochloride and trifluoperazine

raloxifene hydrochloride has been researched along with trifluoperazine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bern, HA; Chou, YC; Iguchi, T1
Bram, Y; Chen, S; Copertino, DC; Duarte, RRR; Han, Y; IƱiguez, LP; Marston, JL; Nixon, DF; Powell, TR; Schwartz, RE1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and trifluoperazine

ArticleYear
Effects of antiestrogens on adult and neonatal mouse reproductive organs.
    Reproductive toxicology (Elmsford, N.Y.), 1992, Volume: 6, Issue:5

    Topics: Animals; Animals, Newborn; Body Weight; Clomiphene; Estrogen Antagonists; Female; Genitalia, Female; Genitalia, Male; Male; Mice; Mice, Inbred C57BL; Nafoxidine; Organ Size; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Trifluoperazine; Uterus; Vagina

1992
Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.
    Molecular medicine (Cambridge, Mass.), 2021, 09-09, Volume: 27, Issue:1

    Topics: Antiviral Agents; Atorvastatin; Cell Line; Coronavirus 3C Proteases; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Doxycycline; Drug Approval; Drug Repositioning; Gene Expression Regulation; Humans; Lung; Models, Biological; Molecular Docking Simulation; Organoids; Raloxifene Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Trifluoperazine; United States; United States Food and Drug Administration; Vesiculovirus; Virus Internalization

2021